NCT05641818

Brief Summary

Validation of a screening tool for identification of subjects at risk for suboptimal vitamin D status. Developed questionnaire-based screening tool will be used on subjects with various risks for vitamin D deficiency, and compared with 25-OH-vitamin D levels.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

December 5, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

10 months

First QC Date

November 29, 2022

Last Update Submit

December 13, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference between vitamin D status (deficiency) assessed by two different methods

    Vitamin D serum level will be measured for assessment of Vitamin D status. Risk for vitamin D deficiency will be assessed using questionaire-based screening tool. Two methods will be compared.

    1 year

Interventions

(1) Determination of 25(OH) Vitamin D3 in human serum samples and (2) Question based screening tool with personal (age, gender,...), lifestyle (e.g. sun exposure, outdoor activity) and dietary factors that affect the status of vitamin D in the human body.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult users and non-users of vitamin D drugs and food supplements living in Slovenia. Participants invited from the database at Nutrition Institute.

You may qualify if:

  • Signed Informed consent form (ICF),
  • Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
  • Did not change use of vitamin D conatining drugs/supplements for last 6 weeks
  • Willingness to follow all study procedures

You may not qualify if:

  • Pregnancy or breastfeeding,
  • Change in use of food supplements containing Vitamin D in last 6 weeks
  • Acute ilness
  • Mental incapacity that precludes adequate understanding or cooperation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nutrition Institute, Ljubljana

Ljubljana, 1000, Slovenia

Location

Related Links

Study Officials

  • Igor Pravst, PhD

    Institut za nutricionistiko

    STUDY CHAIR
  • Katja Žmitek, PhD

    VIST - Faculty of Applied Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2022

First Posted

December 8, 2022

Study Start

December 5, 2022

Primary Completion

October 1, 2023

Study Completion

December 1, 2023

Last Updated

December 14, 2022

Record last verified: 2022-12

Locations